CN Patent
CN100420437C — 磷酸川芎嗪缓释微丸及制备方法
Assigned to China Pharmaceutical University · Expires 2008-09-24 · 18y expired
What this patent protects
本发明涉及药物制剂领域,具体涉及磷酸川芎嗪缓释微丸及制备方法。本发明的磷酸川芎嗪的缓释微丸制剂由两种不同释药行为的缓释微丸组成,使药物能迅速释放达到一定的血药浓度,并且释药一直维持在一个水平上,使血药浓度平稳,达到较理想的治疗效果。
USPTO Abstract
本发明涉及药物制剂领域,具体涉及磷酸川芎嗪缓释微丸及制备方法。本发明的磷酸川芎嗪的缓释微丸制剂由两种不同释药行为的缓释微丸组成,使药物能迅速释放达到一定的血药浓度,并且释药一直维持在一个水平上,使血药浓度平稳,达到较理想的治疗效果。
Drugs covered by this patent
- Ativan (lorazepam) · Generic (originally Wyeth/Pfizer)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.